Skip to main content

Table 3 Therapeutic regimens used based on genetic alterations

From: Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience

Therapeutic regimen

Genetic alterations

Patient number

Cetuximab

KRAS/NRAS/BRAF wild type

22

Trastuzumab

ERBB2 amplification

8

Olaparib

BRCA1/2 mutation

4

Pembrolizumab

MSI-H

2

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us